Results 251 to 260 of about 69,426 (314)

Long‐Term Outcomes and Follow‐Up Management in Patients With Ventricular Tachycardia Electrical Storm After Catheter Ablation

Clinical Cardiology, Volume 49, Issue 1, January 2026.
Zhijie Song, Haizhen Guo
wiley   +1 more source

Fatal Tumor Lysis Syndrome Induced by Pembrolizumab in Advanced Renal Pelvis Cancer

IJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Tumor lysis syndrome (TLS) arises from the rapid breakdown of tumor cells during oncological treatment. Although TLS is rarely observed in solid tumors, few studies have documented instances of TLS associated with pembrolizumab. This report presents a case involving pembrolizumab‐induced TLS.
Takashi Asakura, Toshiaki Shinojima, Shinnosuke Hiruta, Hirotaka Asakura   +3 more
wiley   +1 more source

Successful Treatment of Granulocyte Colony‐Stimulating Factor‐Related Aortitis in Prostate Cancer

IJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction The frequency of granulocyte colony‐stimulating factor‐related aortitis is low. We report a case of successful corticosteroid treatment in a patient with prostate cancer who developed aortitis following pegfilgrastim administration.
Shota Yamada, Kota Amamoto, Nobuhide Maekawa, Kazusato Hara, Takahisa Iwata, Yushi Imasato, Tomohiro Matsuo, Masataka Furukawa, Ryoichi Imamura   +8 more
wiley   +1 more source

Quality Infrastructure for Resilient Pharmaceutical Manufacturing in Ethiopia: A Comparative Archival Review

Journal of Critical Infrastructure Policy, Volume 7, Issue 1, Spring/Summer 2026.
ABSTRACT The National Quality Infrastructure (NQI) in a given country provides the essential framework for quality assurance integrating standardization, metrology, accreditation, and conformity assessment to create the technical backbone for industry and trade. Hence, building a resilient NQI is fundamental to securing medicine quality, enabling local
Addisu Afrassa Tegegne, Mesfin Demissie Woldecherkos, Habtewold Deti Waktola, Sultan Suleman   +3 more
wiley   +1 more source

Duplicate Detection Will Advance with Technology: Yet Underreporting Remains the Core Challenge. [PDF]

Hosp Pharm
Belančić A, Potočnjak I, Mas P.
europepmc   +1 more source

Pharmacovigilance [PDF]

, 2020
openaire   +1 more source

\firstpage 1 \pubyear2025 \keywordkeyword 1; keyword 2; keyword 3 (List three to ten pertinent keywords specific to the article; yet reasonably common within the subject discipline.) Macitentan adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2013 to 2024 [PDF]

Chenyue Gu, Yuanyuan Huang, Lingzhun Wang, Haibo Shi   +3 more
openalex   +1 more source

Incidence of Diabetic Ketoacidosis in Dapagliflozin‐Treated Japanese Patients With Type 1 Diabetes Mellitus: An Observational Cohort Database Study

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 1, January 2026.
ABSTRACT Purpose Diabetic ketoacidosis (DKA) is an important identified risk of treatment with the sodium‐glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin, particularly in patients with type 1 diabetes mellitus (T1DM). We evaluated the DKA incidence rate (IR) among dapagliflozin‐treated Japanese patients with T1DM receiving concomitant insulin.
Reiko Tamura, Hyosung Kim, Yuko Takumi, Miyo Ishihara, Tomoko Kobayashi, Deborah Layton, Kei Sakamoto   +6 more
wiley   +1 more source

Association between exposure to proton pump inhibitors and hypertension: a descriptive and disproportionality analysis of VigiBase. [PDF]

BMJ Open
Chretien B, Cacquevel M, Kazuki N, Guérin C, Dolladille C, Alexandre J, Humbert X.   +6 more
europepmc   +1 more source

NAPaR : European non-interventional post-authorisation safety study of pattern of use and safety of Nordic aprotinin [PDF]

, 2019
De Hert, Stefan, Ouattara, A., Royston, D., Van Der Linden, J., Zacharowski, K.   +4 more
core